Viagra and Pharma: A Risky Investment ?

The legacy of Viagra offers a tangled case study for pharmaceutical stakeholders. Initially a phenomenal success, creating billions in income , the exclusivity end has exposed the difficulties of relying on a isolated product. While generic versions have drastically eroded share, questions remain

read more